ConductScience.org, home

Paper42777046PubMed

Transmembrane delivery of antimicrobial peptides by engineered eCIS into macrophages for intracellular mycobacteria elimination.

Wu Q and 10 others. Sci Adv, 2026.

Cite this record

ConductScience Library. Transmembrane delivery of antimicrobial peptides by engineered eCIS into macrophages for intracellular mycobacteria elimination. Papers, record 42777046. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42777046

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Transmembrane delivery of antimicrobial peptides by engineered eCIS into macrophages for intracellular mycobacteria elimination.
Journal
Sci Adv
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-09-25

Source PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antimicrobial PeptidesMajor topic
MacrophagesMajor topic
MycobacteriumMajor topic
Drug Delivery SystemsMajor topic
Animals
Mice
Mycobacterium tuberculosis
Mycobacterium smegmatis
Photorhabdus
Mycobacterium bovis
Macrophages, Alveolar

Source PubMed

Download CSV of topics

References85

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123060610CD-HIT: accelerated for clustering the next-generation sequencing data.Bioinformatics2012https://conductscience.org/library/papers/23060610PubMed
235489657Strategies for improving antimicrobial peptide production.Biotechnol Adv2022https://conductscience.org/library/papers/35489657PubMed
318691913Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death.Immunity2008https://conductscience.org/library/papers/18691913PubMed
439412514Intestinal microbiome dysbiosis increases Mycobacteria pulmonary colonization in mice by regulating the Nos2-associated pathways.Elife2024https://conductscience.org/library/papers/39412514PubMed
536905712Antimicrobial peptides for combating drug-resistant bacterial infections.Drug Resist Updat2023https://conductscience.org/library/papers/36905712PubMed
639887565Tuberculosis: An Update for the Clinician.Respirology2025https://conductscience.org/library/papers/39887565PubMed
728852964PPAR-γ and Akt regulate GLUT1 and GLUT3 surface localization during Mycobacterium tuberculosis infection.Mol Cell Biochem2018https://conductscience.org/library/papers/28852964PubMed
829589538Antimicrobial peptides for the treatment of pulmonary tuberculosis, allies or foes?Curr Pharm Des2018https://conductscience.org/library/papers/29589538PubMed
910611360Mycobacterial infection of macrophages results in membrane-permeable phagosomes.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10611360PubMed
1036924097Antimicrobial Peptides: A Promising Strategy for Anti-tuberculosis Therapeutics.Protein Pept Lett2023https://conductscience.org/library/papers/36924097PubMed
1128890547Innate immunity in tuberculosis: host defense vs pathogen evasion.Cell Mol Immunol2017https://conductscience.org/library/papers/28890547PubMed
1238147812Antimicrobial peptides: An alternative to traditional antibiotics.Eur J Med Chem2024https://conductscience.org/library/papers/38147812PubMed
1322851964PPARγ Expression and Function in Mycobacterial Infection: Roles in Lipid Metabolism, Immunity, and Bacterial Killing.PPAR Res2012https://conductscience.org/library/papers/22851964PubMed
1439287392Elucidating the molecular properties and anti-mycobacterial activity of cysteine peptidase domain of D29 mycobacteriophage endolysin.J Virol2024https://conductscience.org/library/papers/39287392PubMed
1510573420Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice.Nature1999https://conductscience.org/library/papers/10573420PubMed
1638730558Optimized expression of Peptidyl-prolyl cis/transisomerase cyclophilinB with prokaryotic toxicity from Sporothrix globosa.J Ind Microbiol Biotechnol2024https://conductscience.org/library/papers/38730558PubMed
1736982277Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets.Int J Mol Sci2023https://conductscience.org/library/papers/36982277PubMed
1838705792[Update on the treatment of tuberculosis].Med Clin (Barc)2024https://conductscience.org/library/papers/38705792PubMed
1923329690MAFFT multiple sequence alignment software version 7: improvements in performance and usability.Mol Biol Evol2013https://conductscience.org/library/papers/23329690PubMed
2036195597Expression strategies for the efficient synthesis of antimicrobial peptides in plastids.Nat Commun2022https://conductscience.org/library/papers/36195597PubMed

See all 85 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42777046

GET https://conductscience.org/api/papers/v1/42777046/references?page=2